Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 14/20 | 0.70 |
| ▸ | OPRK1 | P41145 | 11/20 | 0.70 |
| ▸ | OPRD1 | P41143 | 9/20 | 0.70 |
| ▸ | MRGPRX2 | Q96LB1 | 2/20 | 0.60 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.60 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.60 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3475526 | 0.94 | OPRM1 (0.81) | OPRM1OPRK1OPRD1MRGPRX2ADRB1 | |
| SCHEMBL29416620 | 0.88 | OPRD1 (0.78) | OPRM1OPRK1OPRD1MRGPRX2ADRB1 | |
| SCHEMBL547917 | 0.88 | OPRD1 (0.78) | OPRM1OPRK1OPRD1MRGPRX2ADRB1 | |
| SCHEMBL1490396 | 0.83 | OPRM1 (1.00) | OPRM1OPRK1OPRD1MRGPRX2ADRB1 | |
| SCHEMBL14107503 | 0.83 | OPRM1 (1.00) | OPRM1OPRK1OPRD1MRGPRX2ADRB1 | |
| SCHEMBL14153815 | 0.83 | OPRM1 (1.00) | OPRM1OPRK1OPRD1MRGPRX2ADRB1 | |
| SCHEMBL15721372 | 0.83 | OPRM1 (1.00) | OPRM1OPRK1OPRD1MRGPRX2ADRB1 | |
| SCHEMBL12830850 | 0.83 | OPRM1 (1.00) | OPRM1OPRK1OPRD1MRGPRX2ADRB1 | |
| SCHEMBL11778970 | 0.81 | OPRM1 (0.89) | OPRM1OPRK1OPRD1MRGPRX2ADRB1 | |
| Codeine SCHEMBL3475523 | 0.79 | OPRD1 (0.88) | OPRM1OPRK1OPRD1MRGPRX2ADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118105390-A | Method for treating addiction | 细胞内治疗公司 | 2024-05-31 | — | — | CN | claimed |
| CN-118829658-A | Method for producing high affinity antibodies to fentanyl | 德国癌症研究中心公共法律基金会 | 2024-10-22 | — | — | CN | disclosed |
| CN-111698987-B | Halogenated derivatives of morphinans and uses thereof | 萨鲁德医疗公司 | 2024-08-13 | — | — | CN | disclosed |
| CN-117899209-A | Vaccination and antibody production platform | 德国癌症研究公共权益基金会 | 2024-04-19 | — | — | CN | disclosed |
| CN-117425652-A | Novel salts and crystals | 细胞内治疗公司 | 2024-01-19 | — | — | CN | disclosed |
| CN-111093664-B | Organic compound | 细胞内治疗公司 | 2023-06-02 | — | — | CN | disclosed |